Telithromycin in Respiratory Tract Infections

NCT00261105 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Infections

Interventions

DRUG: telithromycin

Sponsor

Sanofi